Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Recruiting · NCT03384238 · Registry updated 2026-03-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery | pancreatic adenocarcinoma | Recruiting | Phase 1 / Phase 2 | 2026-03-17 | NCT03384238 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| George Poultsides | 1 |
| National Cancer Institute (NCI) | 3015 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Stanford University, School of Medicine | Palo Alto | United States | 5 |